Literature DB >> 23796563

Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells.

Valeria G Antico Arciuch1, Marika A Russo, Kristy S Kang, Antonio Di Cristofano.   

Abstract

Rapidly proliferating and neoplastically transformed cells generate the energy required to support rapid cell division by increasing glycolysis and decreasing flux through the oxidative phosphorylation (OXPHOS) pathway, usually without alterations in mitochondrial function. In contrast, little is known of the metabolic alterations, if any, which occur in cells harboring mutations that prime their neoplastic transformation. To address this question, we used a Pten-deficient mouse model to examine thyroid cells where a mild hyperplasia progresses slowly to follicular thyroid carcinoma. Using this model, we report that constitutive phosphoinositide 3-kinase (PI3K) activation caused by PTEN deficiency in nontransformed thyrocytes results in a global downregulation of Krebs cycle and OXPHOS gene expression, defective mitochondria, reduced respiration, and an enhancement in compensatory glycolysis. We found that this process does not involve any of the pathways classically associated with the Warburg effect. Moreover, this process was independent of proliferation but contributed directly to thyroid hyperplasia. Our findings define a novel metabolic switch to glycolysis driven by PI3K-dependent AMPK inactivation with a consequent repression in the expression of key metabolic transcription regulators. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23796563      PMCID: PMC3766458          DOI: 10.1158/0008-5472.CAN-13-1429

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

Review 1.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.

Authors:  Sophia Y Lunt; Matthew G Vander Heiden
Journal:  Annu Rev Cell Dev Biol       Date:  2011       Impact factor: 13.827

2.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells.

Authors:  Junyu Ning; Gang Xi; David R Clemmons
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

Review 3.  Revisiting the TCA cycle: signaling to tumor formation.

Authors:  Nuno Raimundo; Bora E Baysal; Gerald S Shadel
Journal:  Trends Mol Med       Date:  2011-07-20       Impact factor: 11.951

4.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 5.  Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network.

Authors:  Richard C Scarpulla
Journal:  Biochim Biophys Acta       Date:  2010-10-13

6.  Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.

Authors:  Qian Sun; Xinxin Chen; Jianhui Ma; Haiyong Peng; Fang Wang; Xiaojun Zha; Yanan Wang; Yanling Jing; Hongwang Yang; Rongrong Chen; Long Chang; Yu Zhang; June Goto; Hiroaki Onda; Tong Chen; Ming-Rong Wang; Youyong Lu; Han You; David Kwiatkowski; Hongbing Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

Review 7.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Nat Cell Biol       Date:  2011-09-02       Impact factor: 28.824

8.  Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo.

Authors:  Kelly A Miller; Nicole Yeager; Kristen Baker; Xiao-Hui Liao; Samuel Refetoff; Antonio Di Cristofano
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 9.  The metabolic advantage of tumor cells.

Authors:  Maurice Israël; Laurent Schwartz
Journal:  Mol Cancer       Date:  2011-06-07       Impact factor: 27.401

10.  Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors.

Authors:  Valeria G Antico Arciuch; Marika A Russo; Mariavittoria Dima; Kristy S Kang; Florence Dasrath; Xiao-Hui Liao; Samuel Refetoff; Cristina Montagna; Antonio Di Cristofano
Journal:  Oncotarget       Date:  2011-12
View more
  20 in total

1.  Obesity and thyroid cancer: is leptin the (only) link?

Authors:  Antonio Di Cristofano
Journal:  Endocrinology       Date:  2013-08       Impact factor: 4.736

Review 2.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

3.  Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status.

Authors:  Marina Comelli; Ivan Pretis; Alessia Buso; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2017-12-06       Impact factor: 2.945

4.  UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals.

Authors:  Jianhua Yu; Lawrence Shi; Xinggui Shen; Yunfeng Zhao
Journal:  Biochem Pharmacol       Date:  2019-05-11       Impact factor: 5.858

Review 5.  Cell Cycle Control by PTEN.

Authors:  Andrew Brandmaier; Sheng-Qi Hou; Wen H Shen
Journal:  J Mol Biol       Date:  2017-06-09       Impact factor: 5.469

Review 6.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

7.  Down-regulation of MEIS1 promotes the maturation of oxidative phosphorylation in perinatal cardiomyocytes.

Authors:  Isa M Lindgren; Rachel R Drake; Natasha N Chattergoon; Kent L Thornburg
Journal:  FASEB J       Date:  2019-03-18       Impact factor: 5.191

8.  THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER.

Authors:  B I Aydoğan; C C Ersöz; S D Sak; S Güllü
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

Review 9.  Metabolic Role of PTEN in Insulin Signaling and Resistance.

Authors:  Yu Zhe Li; Antonio Di Cristofano; Minna Woo
Journal:  Cold Spring Harb Perspect Med       Date:  2020-08-03       Impact factor: 5.159

Review 10.  Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?

Authors:  D Grahame Hardie
Journal:  Clin Cancer Res       Date:  2015-07-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.